Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01761006 · ClinicalTrials.gov registry record
Evaluation of FeNO During and Following Acute COPD Exacerbation
A clinical trial, sponsored by Wake Forest University.
- Terminated
- Registry status
- 10
- Enrollment target
NCT01761006: Clinical Trial study, sponsored by Wake Forest University.
NCT01761006 is a clinical trial that was terminated before completion, run by Wake Forest University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01761006 was terminated before completion, sponsored by Wake Forest University.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine whether exhaled nitric oxide (FeNO) goes up during an acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) and whether the level of exhaled nitric oxide returns to normal in the weeks after an exacerbation.
Interventions
- DEVICE NIOX MINO®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-09-23 |
Why NCT01761006 stopped before completion
NCT01761006 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which NIOX MINO® is the first listed.
NCT01761006 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01761006 about?
NCT01761006 is a clinical study titled "Evaluation of FeNO During and Following Acute COPD Exacerbation". The purpose of this research study is to determine whether exhaled nitric oxide (FeNO) goes up during an acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) and whether the level of exhaled nitric oxide returns to normal in the weeks after an exacerbation.
What is the current status of trial NCT01761006?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2013-03. Estimated completion is 2014-09-23.
What interventions are being tested in trial NCT01761006?
The interventions under investigation include: NIOX MINO® (DEVICE).
Who is sponsoring clinical trial NCT01761006?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia